phrykt

Helus Pharma Inc. (HELP): who owns it and who trades it

As of Nov 16, 2026, HELP insiders reported 8 purchases worth $8.4M in the last 12 months. The largest buyer was Eric H. L. So (Chair), with $3.6M.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, HELP insiders reported $8.4M of open-market purchases and $0 of sales.

Purchases, 12 months
$8.4M
8 trades, 4 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Sep 29, 2026
Filed Oct 1, 2026

Purchases and sales by month

$7.4M$7.4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 29, 2026Greg CaversCFOPurchase3,000$12.91$38.7KForm 4
Sep 21, 2026Michael HalsteadCEOPurchase100,000$13.47$1.3MForm 4
Sep 8, 2026Paul GlavineChief Growth OfficerPurchase100,000$12.47$1.2MForm 4
Sep 8, 2026Eric H. L. SoChairPurchase100,000$12.39$1.2MForm 4
Sep 4, 2026Eric H. L. SoChairPurchase100,000$12.09$1.2MForm 4
Sep 3, 2026Paul GlavineChief Growth OfficerPurchase100,000$11.78$1.2MForm 4
Sep 1, 2026Eric H. L. SoChairPurchase95,000$11.81$1.1MForm 4
Aug 31, 2026Paul GlavineChief Growth OfficerPurchase90,000$11.59$1MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Eric H. L. SoExecutive Chair, Director$3.6M–Sep 8, 2026
Paul GlavineChief Growth Officer$3.5M–Sep 8, 2026
Michael HalsteadChief Executive Officer$1.3M–Sep 21, 2026
Greg CaversChief Financial Officer$38.7K–Sep 29, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

HELP short interest

2.66M HELP shares are sold short. Over the last 12 reports the number of shares short went up 2%.

As of Oct 30, 2026, 2.66M HELP shares were sold short, down 11.5% from the report before. At the average daily volume of 1.30M shares, buying them all back would take about 2.0 trading days (days to cover).

Shares short

2.66MMay 15Oct 303.59M

Days to cover

2.0May 15Oct 305.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20262.66M–-11%1.30M2.0
Oct 15, 20263.01M–-13%1.54M1.9
Sep 30, 20263.46M–+7%1.99M1.7
Sep 15, 20263.23M–+7%1.39M2.3
Aug 31, 20263.02M–-6%1.53M2.0
Aug 14, 20263.20M–+1%2.32M1.4
Jul 31, 20263.15M–-3%1.89M1.7
Jul 15, 20263.26M–+9%1.14M2.9
Jun 30, 20263.00M–-4%1.90M1.6
Jun 15, 20263.11M–+11%596,6305.2
May 29, 20262.80M–+7%681,3044.1
May 15, 20262.62M–+3%785,7523.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named HELP in the last 120 days.

FiledHolderFormStake
Nov 16, 2026ORBIMED ADVISORS LLC13G/A0.7%
Nov 16, 2026Venrock Healthcare Capital Partners III, L.P.13G/A3.5%
Nov 16, 2026ORBIMED ADVISORS LLC13G/A0.7%
Nov 16, 2026Venrock Healthcare Capital Partners III, L.P.13G/A3.5%
Nov 12, 2026Adage Capital Management, L.P.13G/A7.5%
Nov 12, 2026Adage Capital Management, L.P.13G/A7.5%
Nov 12, 2026Integrated Core Strategies (US) LLC13G/A0.9%
Nov 12, 2026Integrated Core Strategies (US) LLC13G/A0.9%

Questions about Helus Pharma Inc. (HELP) stock

Are HELP insiders buying or selling?

In the last 12 months, HELP insiders reported 8 open-market purchases worth $8.4M and no sales. The latest trade was on Sep 29, 2026. See every trade.

What is the short interest in HELP?

As of Oct 30, 2026, 2.66M HELP shares were sold short, down 11.5% from the report before. At the average daily volume of 1.30M shares, buying them all back would take about 2.0 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.